arrow_back Back to App

Affordable Inhalers Act: Lowering Costs for Breathing Disorder Treatments

This act aims to significantly reduce the cost of inhaler medications and equipment for individuals with breathing disorders like asthma and COPD. Insured individuals will pay a maximum of $15 for a 30-day supply, and uninsured individuals will also have access to these medications at a reduced price. These changes are set to take effect from January 1, 2026, making essential treatment more accessible.
Key points
Maximum out-of-pocket cost for a 30-day supply of specified inhaler products will be $15 for those with private insurance, Medicare Part B, and Part D.
Cost-sharing for inhaler products will count towards deductibles and out-of-pocket maximums.
Uninsured individuals will be able to obtain specified inhaler products for a maximum of $15 per 30-day supply through a new payment program.
The act covers a wide range of inhaler drugs (e.g., aerosols, dry powder inhalers, solutions) and administration equipment (e.g., nebulizers, spacers).
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_2756
Sponsor: Sen. Alsobrooks, Angela D. [D-MD]
Process start date: 2025-09-10
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Affordable Inhalers and Nebulizers Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_2756.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-09-10.

What are the main provisions?

Key points include:

  • Maximum out-of-pocket cost for a 30-day supply of specified inhaler products will be $15 for those with private insurance, Medicare Part B, and Part D.
  • Cost-sharing for inhaler products will count towards deductibles and out-of-pocket maximums.
  • Uninsured individuals will be able to obtain specified inhaler products for a maximum of $15 per 30-day supply through a new payment program.
  • The act covers a wide range of inhaler drugs (e.g., aerosols, dry powder inhalers, solutions) and administration equipment (e.g., nebulizers, spacers).
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Alsobrooks, Angela D. [D-MD].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health